newsfilter
← Latest News
Business Wire·

Prothena Appoints David Ford to Newly Created Chief People Officer Position

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it has named